hormone therapy

The Trump administration has asked the Supreme Court to let it deny hormone therapy to transgender inmates, in a move reported by the New York Times. The filing asks the justices to intervene in litigation over prison healthcare for transgender people. The request is drawing attention from civil rights advocates and reigniting debate over transgender rights and the treatment of incarcerated people under the administration.

Researchers report that biological characteristics of prostate cancer tumours can help identify which patients are most likely to benefit from hormone therapy. The finding suggests tumour biology could be used to tailor treatment decisions rather than applying hormone therapy uniformly. Details of the study, including sample size and clinical impact, were not provided, but the work points toward more personalised prostate cancer care.